We are living through an unprecedented era of new technology development in virtually all sectors of the pharmaceutical industry, most notably electronics/digital technologies, healthcare, manufacturing, consumer practices, and transportation. Ten years ago, who would have thought:
In the health sciences sector, we are witnessing transformational advances in how we treat disease. Scientists are now able to utilize viruses to genetically engineer T-cells to kill specific tumor cells, traditional batch development, and manufacturing processes are giving way to smaller footprints, much more flexible continuous and modular technologies, and something called 3-D printing is now being utilized to manufacture FDA approved drugs.
At the 2017 ISPE Annual Meeting in San Diego on 29 October – 1 November, our Innovation Forum educational track will feature seven exciting sessions that will speak to a variety of the most interesting and impactful innovative technologies in the world today, including some of the ones mentioned above. The session titles below speak to the diversity of topics included in the Innovation Forum:
Join us at some or all of the Innovation Forum sessions. You won’t be disappointed.
The 2017 ISPE Annual Meeting & Expo offers a unique experience, built to expand your professional education and increase your exposure to regulators and industry thought leaders from around the world. Education highlights include:
Through the ISPE Foundation Professional Development Grant program, Silas Tamufor attended the 2023 ISPE Annual Meeting & Expo in October 2023. Tamufor is a PhD student and ISPE Boston Chapter member who began serving as the ISPE Boston Educational Programs Committee Chair in December 2023. He, along with 87 other students and recent graduates, attended the conference thanks to the...
To meet the biopharmaceutical industry’s duty to manufacture safe and effective therapies for patients, a robust quality system is fundamental to success. A quality system should link to quality culture and prioritize focusing on quality, led by management, that fosters sustainable compliance and consistent production of high-quality drugs. Strong quality culture attributes include a proactive...
Stability sampling and testing are key to ensuring that products maintain safety, identity, strength, purity, and quality throughout their claimed shelf life. It is also a regulatory requirement per ICH Q5. However, storing product samples in different environmental conditions, testing those samples for three to five years (or more) after initial manufacture, and properly analyzing and...